Volume 91, Number 9, Supplement 1
RSV immunization in adults and children: A practical guide for clinicians
How to Obtain AMA PRA Category 1 Credit™
- Review information on this page.
- Read the supplement article.
- Return to this page and select the "Complete the CME Process" link.
- Login to your myCME account.
- Complete the registration/evaluation form.
- Print your personalized CME certificate.
Release Date: September 1, 2024
Expiration Date: August 31, 2026
Estimated Time of Completion: 30 minutes
Description
This article reviews the newly approved RSV vaccines for adults and the first long-acting RSV monoclonal antibody for infants and young children. It provides clinicians with practical guidance to navigate this new era of RSV prevention including information on the efficacy and safety of RSV immunizations, and the recommendations for use by the Advisory Committee on Immunization Practices (ACIP). Additionally, it summarizes important information regarding immunization storage and handling, cost and insurance coverage, and best practices for error prevention.
Learning Objectives
- Review the efficacy and safety of RSV immunizations and the recommendations for use by the Advisory Committee on Immunization Practices (ACIP).
- Identify the risks and benefits of RSV immunization and effectively engage patients in the shared clinical decision-making (SCDM) process.
- Explain important information regarding immunization storage and handling, cost and insurance coverage, and best practices for error prevention.
Target Audience
This educational activity is designed for geriatricians, infectious disease physicians, intensivists, nurse practitioners, nurses, obstetricians/gynecologists, pediatricians, pharmacists, physician assistants, primary care physicians, pulmonologists, and other prescribing and non-prescribing providers.
Accreditation
In support of improving patient care, Cleveland Clinic Center for Continuing Education is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Credit Designation
American Medical Association (AMA)
Cleveland Clinic Center for Continuing Education designates this journal-based activity for a maximum of 0.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Participants claiming CME credit from this activity may submit the credit hours to the American Osteopathic Association for Category 2 credit.
American Nurses Credentialing Center (ANCC)
Cleveland Clinic Center for Continuing Education designates this journal-based activity for a maximum of 0.5 ANCC contact hours.
American Academy of PAs (AAPA)
Cleveland Clinic Center for Continuing Education has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 0.5 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.
Accreditation Council of Pharmacy Education (ACPE)
Cleveland Clinic Center for Continuing Education designates this knowledge-based activity for a maximum of 0.5 hours. Credit will be provided to NABP CPE Monitor within 60 days after the activity completion. Universal Activity Number List:
- Pharmacist UAN: JA0000192-0000-24-473-H06-P
Certificate of Participation
A certificate of participation will be provided to other healthcare professionals for requesting credits in accordance with their professional boards and/or associations.
Planning Committee and Authors
Cecile M. Foshee, PhD
Co-Activity Director;
Director, Office of Interprofessional Learning, Cleveland Clinic
Steven M. Gordon, MD
Co-Activity Director;
Chairman, Infectious Disease Department, Cleveland Clinic
Kaitlyn Rivard, PharmD
Co-Activity Director;
Department of Pharmacy, Cleveland Clinic
Nichole Brown, MSN, RN, CHSE-A, PhD(c)
Nursing Institute, Cleveland Clinic
Neal Chaisson, MD
Department of Critical Care Medicine
and Department of Pulmonary Medicine, Cleveland Clinic
Frank Esper, MD
Pediatric Infectious Disease, Cleveland Clinic Children’s Hospital
Debra Kangisser, PA-C
Director of Education;
Physician Assistant Services, Cleveland Clinic
Aanchal Kapoor, MD, Med
Department of Critical Care Medicine
and Department of Pulmonary Medicine, Cleveland Clinic
Steven Kawczak, PhD, CHCP, FACEHP
Co-Medical Director, Center for Continuing Education, Cleveland Clinic
Neil Mehta, MBBS, MS
Center for Technology-Enhanced Knowledge and Instruction, Cleveland Clinic;
Associate Dean of Curricular Affairs, Cleveland Clinic Lerner College of Medicine
of Case Western Reserve University
Anne Vanderbilt, APRN
Senior Director, Advance Nursing Practices Center for Geriatric Medicine, Cleveland Clinic
Hannah Wang, MD
Director, Molecular Microbiology & Virology, Cleveland Clinic
Authors
Trate DeVolld, PharmD, AAHIVP
Department of Pharmacy, Cleveland Clinic, Cleveland, OH
Kaitlyn R. Rivard, PharmD
Department of Pharmacy, Cleveland Clinic, Cleveland, OH
CME Disclaimer
The information in this educational activity is provided for general medical education purposes only and is not meant to substitute for the independent medical judgment of a physician relative to diagnostic and treatment options of a specific patient's medical condition. The viewpoints expressed in this CME activity are those of the authors/faculty. They do not represent an endorsement by The Cleveland Clinic Foundation. In no event will The Cleveland Clinic Foundation be liable for any decision made or action taken in reliance upon the information provided through this CME activity.
Disclosures
In accordance with the Standards for Integrity and Independence issued by the Accreditation Council for Continuing Medical Education (ACCME), The Cleveland Clinic Center for Continuing Education mitigates all relevant conflicts of interest to ensure CME activities are free of commercial bias.
The following faculty have indicated that they have a relationship which, in the context of their contributions, could be perceived as a potential conflict of interest:
Neal Chaisson, MD |
|
Teaching and speaking |
Merck |
|
Consulting, teaching and speaking |
United Therapeutics Corporation |
|
Advisor or review panel participant, teaching and speaking |
Bayer |
Frank Esper, MD |
|
Advisor or review panel participant |
Procter & Gamble |
Kaitlyn Rivard, PharmD |
|
Advisor or review panel participant |
Pfizer |
Hannah Wang, MD |
|
Research: Cepheid may be providing reagents and financial support for a study on which I am principal investigator. The contract is currently under negotiation. |
Cepheid |
|
Research: Hologic is providing reagents for a study in which I am a co-investigator. |
Hologic |
The following faculty have indicated they have no relationship which, in the context of their presentation, could be perceived as a potential conflict of interest:
Nichole Brown, MSN, BSN
Trate DeVolld, PharmD, AAHIVP
Cecile M. Foshee, PhD
Steven Mark Gordon, MD
Debra Kangisser, PA-C
Aanchal Kapoor, MD
Steven Kawczak, PhD
Neil Mehta, MD
Anne Vanderbilt, APRN
(Article opens in a new tab / window; return to this window to complete the activity).
The Cleveland Clinic Center for Continuing Education acknowledges an educational grant for support of this activity
from ModernaTX, Inc.
This CME activity was produced by the Cleveland Clinic Journal of Medicine and the Cleveland Clinic Center for Continuing Education.